The profunda artery perforator flap in autologous breast reconstruction: a scientific review Authors: Kevin M McGarry, Jenny Chen, Rebecca L DeSanti, Jonas A Nelson, Robert J Allen Published: 2025 ABSTRACT AbstractIn oncologic breast reconstruction, autologous techniques have been demonstrated to provide patients with improved long-term outcomes and fewer complications than implant-based techniques, especially in the setting of adjunct therapies. While the deep inferior epigastric perforator (DIEP) flap remains the gold standard, not all patients are suitable candidates due to insufficient abdominal tissue or prior abdominal surgeries. Recent advances in microsurgical and imaging techniques, such as computed tomography angiography (CTA) for perforator mapping, have provided reconstructive surgeons with the ability to reliably harvest perforator-based flaps from various areas of the body that minimize donor site morbidity while maximizing reconstructive success. The profunda artery perforator (PAP) flap has emerged as a useful tool in the reconstructive microsurgeon’s armamentarium for breast reconstruction in patients where more traditional donor sites are inappropriate or unavailable. Harvested from the posteromedial thigh, this fasciocutaneous flap preserves underlying muscle function and offers distinct advantages, including a reliable vascular pedicle and a discreetly hidden scar. This review article outlines the development of the flap, recent modifications, and relevant surgical anatomy, ultimately synthesizing current clinical outcomes to validate the PAP flap as a robust and aesthetically superior alternative for restoring natural breast contour.Keywords: Profunda artery perforator flap (PAP flap), autologous breast reconstruction, microsurgery Introduction Autologous breast reconstruction has evolved significantly over the past three decades, driven largely by advances in microsurgical techniques and a deeper understanding of perforator flap anatomy (1). Following the paradigm shift that occurred with free tissue transfer and the description of the deep inferior epigastric perforator (DIEP) flap in 1992 (2), advances in autologous tissue transfer donor sites have become an area of intense clinical research (3,4). The DIEP flap meets many criteria of the ideal soft tissue breast reconstruction, providing sufficient skin and soft tissue volume for an aesthetic breast. However, for patients who lack adequate abdominal tissue, have had prior abdominal surgery, or who prefer to avoid an abdominal scar, the profunda artery perforator (PAP) flap has recently become the preferred alternative flap (5,6). Harvested from the posteromedial thigh, the PAP flap provides a fasciocutaneous flap with a reliable perforator-based blood supply from the profunda femoris artery (PFA). Notable benefits of this flap include favorable donor site morbidity, hidden scarring, and a robust vascular supply (7). Although the PAP flap generally offers a smaller volume than abdominally-based flaps, it can be raised as an extended flap with a significant subcutaneous chamfer, or bevel, with superior and inferior extensions to increase both width and volume of the flap (8). This review provides a comprehensive overview of the PAP flap in autologous breast reconstruction, detailing the relevant anatomy, surgical technique, clinical outcomes, and a discussion regarding recognized complications, relative advantages, and limitations of the flap. Background In oncologic breast reconstruction, autologous tissue-based breast options offer higher long-term reconstructive success rates, improved patient satisfaction, and avoid many of the recognized complications associated with implant-based approaches, such as early implant loss and capsular contracture (9). Advances in microsurgical perforator flap techniques have allowed surgeons to minimize donor site morbidity while maximizing both short- and long-term reconstructive outcomes. While the DIEP flap remains the gold standard for autologous breast reconstruction, it is not suitable for all patients. Individuals with insufficient abdominal tissue, prior abdominal surgeries, or those seeking to avoid an abdominal scar may require flap harvest from an alternative donor site. The thigh-, buttock-, and back-based flaps have emerged as valuable competing autologous tissue options, offering pliable soft tissue with well-described perforator anatomy (10,11). Historically, the transverse upper gracilis (TUG) myocutaneous flap was the alternative flap of choice for breast reconstruction (12), but the PAP flap has gained rapid acceptance and popularity as a true thigh-based perforator flap over the last number of years with recent robust patient outcome data to support its use (13). The PAP flap involves harvesting skin and subcutaneous fat from the posteromedial thigh, either in a transverse or longitudinal orientation, based on perforators originating from the PFA. This approach often yields a well-concealed donor site scar in the gluteal fold, with minimal functional impairment on the lower extremity. Over the past decade, multiple studies have documented high flap survival rates, favorable aesthetic outcomes, and reproducible surgical techniques for the PAP flap (14). By synthesizing the published literature and reflecting on our own clinical experience, we aim to clarify the role of the PAP flap as a reliable alternative or adjunct to the DIEP flap in selected breast reconstruction patients. Anatomy and vascular considerations The PAP flap is based on the PFA (also referred to as the deep femoral artery), which arises from the common femoral artery approximately 3–4 cm below the inguinal ligament. As the PFA travels posteriorly along the femur, it gives off multiple perforating vessels that penetrate or course between the adductor musculature and supply the overlying skin and fat of the posterior and medial thigh. Typically, the largest and most consistent perforator for the PAP flap is located within a few centimeters of the gluteal crease, often emerging through or immediately adjacent to the adductor magnus (AM). These perforators may be musculocutaneous (traversing through the muscle) or septocutaneous (coursing along fascial planes), influencing the dissection approach (15). Preoperative imaging in the form of computed tomography angiography (CTA) or magnetic resonance angiography (MRA), is used to identify dominant perforators, assess their size and trajectory, and estimate pedicle length (Figure 1). Imaging can also help guide flap design and reduce intraoperative exploration time. Preoperative MRA scans utilized by the senior author for operative planning. (A) 3D MRA rendering highlighting the location of profunda artery perforators on the posteromedial thigh. (B) Axial MRA demonstrating the intramuscular course of one of the dominant perforators (R4). 3D, three-dimensional; MRA, magnetic resonance angiography. Once identified, the perforator(s) are dissected either septocutaneously or intramuscularly to their origin at the PFA. Reported pedicle lengths for the PAP flap range from 8 to 14 cm, with vessel diameters typically around 2–3 mm (16). The skin island can be oriented transversely or longitudinally along the posterior thigh, and a cutaneous nerve can be included with the pedicle for neurotization if desired (17). Given that the AM is left intact (as the flap is purely perforator-based), donor site morbidity is minimized, and thigh motor function is preserved. Preoperative planning and surgical approach In our institution, all patients undergo preoperative imaging to accurately locate and assess the reliability of perforators in the posterior thigh, although this is not an absolute requirement due to the reliability of the vasculature anatomy. It is the senior author’s preference to obtain preoperative MRA to assist with operative planning, but CTA is a suitable alternative. In cases where imaging is not pursued, perforator location could also be identified using surface landmarks described above and confirmed with a handheld Doppler ultrasound. MRA is the senior authors’ investigation of choice due to lack of associated radiation as well as improved visualization of the perforators through the muscle and soft tissues as compared to CTA. For patients who might be claustrophobic or cannot readily undergo MRA, CTA or ultrasound can easily be employed for preoperative planning. Patient positioning for PAP flap harvest varies based on surgical preference, with options including the supine ‘frog-leg’ position, prone position, or lateral decubitus. However, the lithotomy position is the senior author’s preferred approach, as it provides improved access to the posterior aspect of the flap. The supine frog-leg and lithotomy positions eliminate the need for patient repositioning after flap harvest, allowing a simultaneous two-team approach for chest vessel preparation and flap harvest. Care should be taken to ensure adequate leg support and avoid compression points that could lead to pressure injury or neuropathy, most notably the peroneal nerve. Surgical marking is performed following patient positioning. The decision between a transverse, longitudinal, or extended skin paddle is made based on patient anatomy (specifically the location of subcutaneous tissue bulk) and reconstructive goals. The transverse paddle, most commonly used due to its favorable scar location, extends in a crescentic shape from the gracilis anteriorly to the lateral gluteal fold posteriorly, along or just inferior to the gluteal crease (Figure 2). Patient in the lithotomy position with transverse PAP flap skin island markings. PAP, profunda artery perforator. The width of the flap should be kept under 6.5 cm to allow for tension-free closure, though this width may increase in patients with more laxity or a history of weight loss. Surgery begins with the anterior incision along the marked skin paddle and dissection through the subcutaneous tissue. Once muscular landmarks are identified, the inferior incision is made through the skin with an aggressive subcutaneous bevel, or chamfer (Figure 3), to increase flap bulk. The lateral edge of the skin incision is left intact to prevent flap avulsion and maintain perfusion until the recipient vessels are ready. Harvested right PAP flap, highlighting the superior subcutaneous chamfer, or bevel, technique. PAP, profunda artery perforator. After completing the bevel inferiorly to fascia, the dissection proceeds anterior to posterior in a supra-fascial plane. When the gracilis muscle is identified, the fascia is entered throughout the width of the flap. Fish hooks are used to retract the gracilis anteriorly. With the gracilis muscle retracted anteriorly, the AM fascia is visualized. This is incised, and the dissection proceeds posteriorly under the AM fascia. As the dissection is carried posteriorly, careful attention is required to identify the perforator(s) supplying the flap (Figure 4). In many cases, a single robust perforator is sufficient to perfuse the entire flap, even if it is eccentrically located within the subcutaneous tissue rather than directly below the skin island. Since PAP vessels most often traverse intramuscularly through the AM, meticulous intramuscular dissection under loupe magnification is typically required to preserve vessel integrity. If encountered, motor nerves to the adductor muscles should be preserved. Once the perforator is fully dissected to its takeoff from the PFA and adequate pedicle length is confirmed, the pedicle is divided, and a microvascular clamp is placed across the pedicle. Finally, the remaining posterior flap attachments-comprising skin and subcutaneous tissue-are released, completing flap harvest. Intraoperative view of a PAP flap harvest. (A) The gracilis muscle (G) is exposed, with sub-fascial dissection of the AM visible. Perforators (1, 2, and 3) are identified. (B) Perforator 2 chosen as the ideal perforator, which is dissected through the AM until adequate length and vessel caliber are obtained or until the PFA is encountered. AM, adductor magnus; PAP, profunda artery perforator; PFA, profunda femoris artery. Simultaneously or immediately after flap dissection, the recipient site in the chest is prepared. In cases of skin-sparing mastectomy, the internal mammary vessels are accessed via the third intercostal space, following standard technique. In cases of nipple-sparing mastectomy performed through the inframammary fold (IMF) approach, the fourth intercostal space may provide better access given the shorter pedicle of the PAP flap. If axillary dissection is indicated or the IMF approach is contraindicated, the thoracodorsal vessels may serve as alternative recipient vessels. Microvascular anastomosis is performed under magnification to restore arterial inflow and venous outflow. The flap is then inset to create a natural breast contour, with attention to symmetry and shape, with the previously discussed chamfer technique drastically improving the breast’s upper pole reconstruction and overall breast shape. The author typically uses each PAP flap for ipsilateral breast reconstruction; however, with consideration to perforator location within the flap, it can be possible and necessary to utilize PAP flaps for contralateral breast reconstruction for more appropriate lie and reach of the pedicle to recipient vessels. If skin replacement is required, a skin paddle is brought out for flap monitoring; otherwise, the flap is de-epithelialized and completely buried beneath the mastectomy skin flaps. Once the flap is transferred, the thigh incision is closed primarily in two layers over suction drains. The previously discussed chamfer technique appears to improve donor site closure as well. The use of progressive tension sutures or drains can help minimize the risk of seroma formation, though these are not frequently used in our practice. Compression shorts and early mobilization (postoperative day 0) are encouraged to reduce the risk of venous thromboembolism. The patients are then managed as part of a standard enhanced recovery protocol. The Foley is removed in recovery, normal diet resumes, and discharge is planned on day one post op for unilateral reconstructions and day two for bilateral cases. Routine labs are not sent after surgery unless there is a clinical concern. Figure 5 provides preoperative and postoperative examples of a patient undergoing PAP flap breast reconstruction. Preoperative (top row) and postoperative (bottom row) views of a patient undergoing unilateral right breast reconstruction with a left PAP flap, and contralateral left breast mastopexy for symmetry. PAP, profunda artery perforator. Discussion Published studies on PAP flap breast reconstruction report high flap survival rates, often exceeding 95–99% (17,18). These results are comparable to those of other free flap procedures, including the DIEP flap. With surgical experience, the PAP perforators can be reliably located, and the intramuscular dissection required is comparable to other perforator flap harvest sites, contributing to these favorable results. As a true perforator flap, the PAP flap preserves AM function, resulting in minimal donor site morbidity. The most commonly reported donor site issues include seroma formation, contour irregularities along the posterior thigh, and wound dehiscence or delayed healing, particularly in cases requiring tighter closures or extended incisions (19). Beyond the acute perioperative phase, additional complications at the reconstructed breast site may include fat necrosis, infection, and partial flap necrosis, although these occur at relatively low rates. Fat necrosis, typically presenting as palpable firmness or radiographic density, is often managed conservatively but can be corrected with minor surgical revision if symptomatic or aesthetically concerning (19). Compared to the muscle-sparing transverse rectus abdominis myocutaneous (ms-TRAM) and DIEP flaps, PAP flap reconstruction completely spares the abdomen, thereby eliminating risks of abdominal wall complications, such as bulge and hernia formation (20). This can be particularly advantageous for high-performing patients, where any compromise to core strength is deemed unacceptable, or patients who heavily rely on core strength for mobility. Furthermore, many patients find it a more cosmetically acceptable donor site, as scars are typically well concealed in the posterior thigh or gluteal crease. However, careful preoperative planning is essential, as closure under significant tension can increase the risk of wound breakdown and unfavorable scarring. Patient selection is also crucial, as adequate posteromedial thigh tissue is necessary to harvest a sufficient flap volume. As discussed, PAP flaps generally provide less tissue volume than abdominally-based flaps, even when they are augmented as extended flaps. This can necessitate additional procedures, such as stacked flaps or staged augmentation with fat grafting, for patients seeking a larger breast size, but can be mitigated by the described chamfer technique. Furthermore, compared to abdominally-based reconstructions, the learning curve for PAP flap dissection is relatively steeper. Familiarity with the vascular anatomy of the thigh and precise identification of the correct sub-fascial plane of dissection are critical for ease of harvest and achieving consistent results. In comparison to alternative gluteal-based and lumbar-based flaps, we believe the significant benefit of the PAP flap is the lack of requirement for intraoperative repositioning. Although these alternative autologous flaps can offer similar flap volume, the patient typically needs to be rotated at least once intraoperatively for flap harvest or inset. Using the frog-leg or lithotomy positioning highlighted above, a two-team approach can occur simultaneously at the PAP donor and recipient site, negating the need for intraoperative repositioning and improving surgical efficiency. We also feel that the donor site is more forgiving than the other alternatives, with a more conspicuous scar than the lumbar-based flaps. Historically, we also carried out a significant number of transverse upper gracilis (TUG) myocutaneous flaps. A recent volumetric analysis (21) suggests that PAP flaps provide a higher flap thickness to projection ratio in comparison to TUG flaps and are true perforator flaps, avoiding potential weakness associated with removing the gracilis muscle. The PAP flap is also more posteriorly located than the TUG flap, limiting visualization of the scar from the anterior view, reducing the risk of lymphedema and capturing the best soft tissue for use in breast reconstruction (i.e., the proximal posterior fat of the thigh). Taken in conjunction with a reliable blood supply and long pedicle, the PAP flap has completely replaced gracilis-based flaps at our institution. Conclusions As clinical experience and evidence continue to grow, the PAP flap is emerging as the preferred secondary option for autologous breast reconstruction in patients unsuitable for a DIEP flap. Its utility has been well demonstrated in patients lacking adequate abdominal donor sites or those wishing to avoid an abdominal scar. By leveraging reliable perforator anatomy of the PFA, the PAP flap provides a predictable, well-vascularized fasciocutaneous flap with minimal donor site morbidity and a cosmetically favorable scar. Its success rates and safety profile are comparable to established flaps like the DIEP flap, and ongoing advancements in preoperative imaging, surgical technique, and postoperative management continue to enhance outcomes and patient satisfaction. The chamfer, or bevel, modification has improved upper pole reconstruction and overall breast contour, in addition to improving donor site closure. Future research will likely focus on optimizing patient selection, improving imaging-based perforator mapping, and exploring innovative strategies for increasing flap volume, such as stacking, extended flap harvest, and combined autologous tissue with implant augmentation. Overall, the PAP flap has established itself as a reliable and aesthetically pleasing option in autologous breast reconstruction. Supplementary The article’s supplementary files as Acknowledgments None. Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Written informed consent was obtained from the patient(s) for publication of this article and accompanying images. Footnotes Funding: This work was supported in part by the NIH/NCI Cancer Center Support Grant (No. P30 CA008748). Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-2025-239/coif). The authors have no conflicts of interest to declare. References Available at https://gs.amegroups.com/article/view/10.21037/gs-2025-239/prf Supplementary Materials The article’s supplementary files as